Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis

Journal of Nutrition

Volumn 142, Issue 10, 2012, Pages 1821-1828

  Marcolin, Eder ^a   San Miguel, Beatriz ^b,c   Vallejo, Daniela ^b   Tieppo, Juliana ^b   Marroni, Norma ^a   González Gallego, Javier ^b,c   Tuñón, María J ^b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF LEÓN   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN C JUN; QUERCETIN; SMAD3 PROTEIN; SMAD7 PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; INFLAMMATORY CELL; LIPID PEROXIDATION; LIVER; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER PROTECTION; LIVER WEIGHT; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION;

ANIMALS; BIOLOGICAL MARKERS; CHOLINE; CHOLINE DEFICIENCY; COLLAGEN TYPE I; COLLAGEN TYPE III; CYCLOOXYGENASE 2; DIET; DISEASE MODELS, ANIMAL; FATTY LIVER; FIBROSIS; HMGB1 PROTEIN; INFLAMMATION; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPID PEROXIDATION; LIVER; MALE; METHIONINE; MICE; MICE, INBRED C57BL; NF-KAPPA B; OXIDATIVE STRESS; QUERCETIN; RNA, MESSENGER; SMAD PROTEINS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

MUS; RATTUS;

EID: 84869121923     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.165274     Document Type: Article

References (57)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99-112.
2. Schwabe RF, Brenner DA. Mechanisms of liver injury. I. TNF-alpha induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol. 2006;290:G583-9.
3. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
4. Alisi A, Panera N, Nobili V. Toll-like receptor 4: a starting point for proinflammatory signals in fatty liver disease. Hepatology. 2010;51: 714-5.
5. Yoshida K, Matsuzaki K. Differential regulation of TGF-b/Smad signaling in hepatic stellate cells between acute and chronic liver injuries. Front Physiol. 2012;3:53.
6. Dela Peña A, Leclercq I, Field J, George J, Jones B, Farrell G. NFkappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology. 2005;129: 1663-74.
7. Masterjohn C, Brubo RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev. 2012;70:41-56.
8. Ji G, Yang Q, Hao J, Guo L, Chen X, Hu J, Leng L, Jiang Z. Antiinflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int Immunopharmacol. 2011;11:762-8.
9. Ramirez-Tortosa MC, Ramirez-Tortosa CL, Mesa MD, Granados S, Gil A, Quiles JL. Curcumin ameliorates rabbit steatohepatitis via respiratory chain, oxidative stress, and TNF-a. Free Radic Biol Med. 2009; 47:924-31.
10. Hu CM, Cao Q, Lv XW, Cheng WM, Li R, Li J. Protective effects of total flavonoids from Litsea coreana on alcoholic fatty liver in rats associated with down-regulation of adipose differentiation-related protein expression. Am J Chin Med. 2012;40:599-610.
11. Joven J, Espinel E, Rull A, Aragone's G, Rodríguez-Gallego E, Camps J, Micol V, Herranz-López M, Menéndez JA, Borrás I, et al. Plant-derived polyphenols regulate expression of miRNA paralog miR-103/107 and miR-1222 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim Biophys Acta. 2012;1820:894-9.
12. Schrieber SJ, Hawke RL, Wen Z, Smith PC, Reddy KR, Wahed AS, Belle SH, Afdhal NH, Navarro VJ, Meyers CM, et al. Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Drug Metab Dispos. 2011;39:2182-90.
13. Tuñón MJ, García-Mediavilla MV, Sánchez-Campos S, González-Gallego J. Potential of flavonoids as anti-inflammatory agents: modulation of pro-inflammatory gene expression and signal transduction pathways. Curr Drug Metab. 2009;10:256-71.
14. González-Gallego J, García-Mediavilla MV, Sánchez-Campos S, Tuñón MJ. Fruit polyphenols, immunity and inflammation. Br J Nutr. 2010; 104:S15-27.
15. Martínez-Flórez S, Gutiérrez-Fernández B, Sánchez-Campos S, Gonzá-lez-Gallego J, Tuñón MJ. Quercetin attenuates nuclear factor-kappaB activation and nitric oxide production in interleukin-1beta-activated rat hepatocytes. J Nutr. 2005;135:1359-65.
16. Crespo I, García-Mediavilla MV, Almar M, Gonzalez P, Sánchez-Campos S, Tuñón MJ, Sánchez-Campos S, González-Gallego J. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and antioxidant enzymes in Chang Liver cells. Food Chem Toxicol. 2008;46:1555-69.
17. Peres W, Tuñón MJ, Collado PS, Herrmann S, Marroni N, González-Gallego J. The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol. 2000;33:742-50.
18. Tieppo J, Cuevas MJ, Vercelino R, Tuñón MJ, Marroni NP, González-Gallego J. Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. J Nutr. 2009;139:1339-46.
19. Cuevas MJ, Tieppo J, Marroni NP, Tuñón MJ, González-Gallego J. Suppression of amphiregulin/epidermal growth factor receptor signals contributes to the protective effects of quercetin in cirrhotic rats. J Nutr. 2011;141:1299-305.
20. Egert S, Bosy-Weestphal A, Seiberl J, Kurbitz C, Settler U, Plachta-Danielzik S, Wagner AE, Frank J, Schrezenmaier J, Rimbach J, et al. Quercetin reduces systolic blood pressure and plasma oxidised lowdensity lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebocontrolled cross-over study. Br J Nutr. 2009;102:1065-74.
21. Kobori M, Masumoto S, Akimoto Y, Oike H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res. 2011;55:530-40.
22. Panchal SK, Poudyal H, Brown L. Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr. 2012;142:1026-32.
23. Pastor A, Collado PS, Almar M, González-Gallego J. Microsomal function in biliary obstructed rats: Effects of S-adenosylmethionine. J Hepatol. 1996;24:353-9.
24. Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, González-Gallego J, Tuñón MJ. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis. 2008;14:1504-13.
25. Harrison SA, Neuschwander-Tetri B. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2004;8:861-79.
26. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
27. San-Miguel B, Crespo I, Kretzmann NA, Mauriz JL, Marroni N, Tuñón MJ, González-Gallego J. Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid. J Nutr. 2010;140:1065-71.
28. Crespo I, García-Mediavilla MV, Gutiérrez B, Sánchez-Campos S, Tuñón MJ, González-Gallego J. A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br J Nutr. 2008;100:968-76.
29. Tuñón MJ, San-Miguel B, Crespo I, Jorquera F, Santamaría E, Alvarez M, Prieto J, González-Gallego J. Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J Pineal Res. 2011;50:38-45.
30. Fillmann H, Kretzmann NA, San-Miguel B, Llesuy S, Marroni N, González-Gallego J, Tuñón MJ. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology. 2007;236:217-26.
31. National Center for Biotechnology Information. Entrez Gene [Internet]. Bethesda (MD): National Library of Medicine; 2005 [cited 2012 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene.
32. Almonacid-Urrego CC, Sánchez-Campos S, Tuñón MJ, González-Gallego J. Non-alcoholic steatohepatitis: what can we learn from animal models? Curr Med Chem. 2012;19:1389-404.
33. Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Life Sci. 2012;90:200-5.
34. Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, et al. Deficiency in myeloid differentiation factor-2 and Toll-like receptor 4 expression attenuates non-alcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 2011;300:G433-41.
35. Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology. 2009;49:989-97.
36. Li L, Chen L, Liu Y, Sun HY, Tang J, Hou Y, Chang Y, Tu Q, Feng G, Shen F, et al. Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology. 2011;54: 1620-30.
37. Mas E, Danjoux M, Garcia V, Carpentier S, Seguy B, Levade T. IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PLoS ONE. 2009;4:e7929.
38. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007;204: 2913-23.
39. Cohen JI, Chen X, Nagy LE. Redox signaling and the innate immune system in alcoholic disease. Antioxid Redox Signal. 2011;15:523-34.
40. Granado-Serrano AB, Martin MA, Bravo L, Goya L, Ramos S. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact. 2012;195:154-64.
41. George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol. 2003;39:756-64.
42. Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, Weltman MD, Tilg H, Moschen AR, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology. 2007;133:80-90.
43. Vizzutti F, Provenzano A, Galastri S, Milani S, Delogu W, Novo E, Caligiuri A, Zamara E, Arena U, Laffi G, et al. Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab Invest. 2010; 90:104-15.
44. Wrana JL. Regulation of Smad activity. Cell. 2000;100:189-92.
45. Sundaresan S, Mills N, Imrhan V, Prasad C. A mouse model for nonalcoholic steatohepatitis. J Nutr Biochem. 2011;22:979-84.
46. Magro F, Costa C. Long standing remission of Crohn's disease under imatinib therapy in patients with Crohn's disease. Inflamm Bowel Dis. 2006;12:1087-9.
47. Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Santamaria M, Lee DC, Prieto J, Avila MA. Novel role for amphiregulin in protection from liver injury. J Biol Chem. 2005;280:19012-20.
48. Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goñi S, Vespasiani-Gentilucci U, Zagami MG, Lotersztajn S, Prieto J, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology. 2008;48:1251-61.
49. Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2008;23:1909-16.
50. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52: 1836-46.
51. Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, Friedman JE. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology. 2007;45:1108-17.
52. Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC. Peroxisome proliferator-activated receptor-a agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2012;27: 341-50.
53. Park HJ, Lee JY, Chung MY, Park YK, Bower AM, Koo SI, Giardina C, Bruno RS. Green tea extract suppresses NFkB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J Nutr. 2012;142:57-63.
54. Aghazadeh S, Yandanparast R. Inhibition of JNK along with activation of ERK1/2 MAPK pathways improves steatohepatitis among the rats. Clin Nutr. 2010;29:381-5.
55. Chen A, Zheng S. Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. Br J Pharmacol. 2008;153:557-67.
56. Leclercq IA, Farrell GC, Sempoux C, dela Peña A, Horsmans Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol. 2004;41:926-34.
57. Imasirio C, Alchera E, Valente G, Bocacfoschi F, Albano E, Carini R. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats. Clin Sci (Lond). 2012;123:323-32.